Credit Ratings

Boston Scientific stock faces negative outlook as growth slows – ad-hoc

By

S&P Global Ratings — Boston Scientific stock faces negative outlook as growth slows  ad-hoc-news.de

Read the original at S&P Global Ratings ↗

Auto-published by the finit.news Events monitor from S&P Global Ratings; summarized by AI and may contain errors — verify against the primary source. November 9, 2026.

By

Related Post

Credit Ratings

Fitch affirms Iraq at ’B-’ with stable outlook as reserves offset oil shock

Credit Ratings

Fitch Ratings revises AFL’s outlook to Negative

Credit Ratings

Kcell : Fitch Ratings upgrades credit rating of Kcell JSC to investment grade “BBB−”, Outlook Stable

Financial News For All

Labor

Hundreds of Portland employees on strike Monday after bargaining falls through

Labor

More than 800 Portland workers are on strike over wages – Oregon Public Broadcasting

Regulatory Approvals

After a 10-year gap, FDA approves new option for pretreated head and neck cancer

Regulatory Approvals

Novocure denied FDA approval for metastatic cancer treatment